Literature DB >> 21091908

Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Karen M Lammers1, Sunaina Khandelwal, Fatima Chaudhry, Debby Kryszak, Elaine L Puppa, Vincenzo Casolaro, Alessio Fasano.   

Abstract

The autoimmune enteropathy, coeliac disease (CD), is triggered by ingestion of gluten-containing grains. We recently reported that the chemokine receptor CXCR3 serves as a receptor for specific gliadin peptides that cause zonulin release and subsequent increase in intestinal permeability. To explore the role of CXCR3 in the immune response to gliadin, peripheral blood mononuclear cells from both patients with CD and healthy controls were incubated with either pepsin-trypsin-digested gliadin or 11 α-gliadin synthetic peptides in the presence or absence of a blocking anti-CXCR3 monoclonal antibody. Supernatants were analysed for interleukin-6 (IL-6), IL-8, IL-10, IL-13, IP-10 (CXCL10), tumour necrosis factor-α and interferon-γ. Gliadin broadly induced cytokine production irrespective of the clinical condition. However, IL-8 production occurred only in a subgroup of individuals and cells of the phagocytic lineage were the main source. Induction of IL-8 was reproduced by one of a comprehensive panel of synthetic α-gliadin peptides and was abrogated when CXCR3 was blocked before stimulation with either gliadin or this peptide in the CD group but not in the control group, suggesting that gliadin-induced IL-8 production was CXCR3-dependent gliadin induced IL-8 production only in CD.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091908      PMCID: PMC3044909          DOI: 10.1111/j.1365-2567.2010.03378.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge.

Authors:  A Picarelli; M Di Tola; L Sabbatella; M C Anania; T Di Cello; R Greco; M Silano; M De Vincenzi
Journal:  Scand J Gastroenterol       Date:  1999-11       Impact factor: 2.423

Review 2.  Plasma-cell homing.

Authors:  Eric J Kunkel; Eugene C Butcher
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

3.  Celiac disease--how to handle a clinical chameleon.

Authors:  Alessio Fasano
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 4.  Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.

Authors:  Giuseppe Penna; Marisa Vulcano; Silvano Sozzani; Luciano Adorini
Journal:  Hum Immunol       Date:  2002-12       Impact factor: 2.850

Review 5.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

6.  Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.

Authors:  Alessio Fasano; Irene Berti; Tania Gerarduzzi; Tarcisio Not; Richard B Colletti; Sandro Drago; Yoram Elitsur; Peter H R Green; Stefano Guandalini; Ivor D Hill; Michelle Pietzak; Alessandro Ventura; Mary Thorpe; Debbie Kryszak; Fabiola Fornaroli; Steven S Wasserman; Joseph A Murray; Karoly Horvath
Journal:  Arch Intern Med       Date:  2003-02-10

7.  Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.

Authors:  Anna Sapone; Karen M Lammers; Giuseppe Mazzarella; Irina Mikhailenko; Maria Cartenì; Vincenzo Casolaro; Alessio Fasano
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

8.  Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.

Authors:  Richard A Colvin; Gabriele S V Campanella; Jieti Sun; Andrew D Luster
Journal:  J Biol Chem       Date:  2004-05-17       Impact factor: 5.157

9.  The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12.

Authors:  Béatrice Vanbervliet; Nathalie Bendriss-Vermare; Catherine Massacrier; Bernhard Homey; Odette de Bouteiller; Francine Brière; Giorgio Trinchieri; Christophe Caux
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  27 in total

1.  Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.

Authors:  Olimpia Vincentini; Francesca Maialetti; Elena Gonnelli; Marco Silano
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

2.  Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin-Trypsin-Resistant Gliadin-Induced Tight Junction Injuries.

Authors:  Shouquan Dong; Tikka Prabhjot Singh; Xin Wei; Huang Yao; Hongling Wang
Journal:  Dig Dis Sci       Date:  2017-09-04       Impact factor: 3.199

Review 3.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

4.  Protective effects of Acetobacter ghanensis against gliadin toxicity in intestinal epithelial cells with immunoregulatory and gluten-digestive properties.

Authors:  Caglar Doguer; Hande Akalan; Nazan Tokatlı Demirok; Berna Erdal; Rafet Mete; Turker Bilgen
Journal:  Eur J Nutr       Date:  2022-09-29       Impact factor: 4.865

5.  Gluten intake and risk of type 2 diabetes in three large prospective cohort studies of US men and women.

Authors:  Geng Zong; Benjamin Lebwohl; Frank B Hu; Laura Sampson; Lauren W Dougherty; Walter C Willett; Andrew T Chan; Qi Sun
Journal:  Diabetologia       Date:  2018-08-03       Impact factor: 10.122

6.  Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients.

Authors:  Benjamin Niland; Brooks D Cash
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

7.  Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.

Authors:  Na Tian; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Eric V Marietta; Joseph A Murray; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

8.  Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity.

Authors:  Jason A Tye-Din; Gry I Skodje; Vikas K Sarna; John L Dzuris; Amy K Russell; Gautam Goel; Suyue Wang; Kaela E Goldstein; Leslie J Williams; Ludvig M Sollid; Knut Ea Lundin; Robert P Anderson
Journal:  United European Gastroenterol J       Date:  2019-09-03       Impact factor: 4.623

9.  Modulatory Effect of Gliadin Peptide 10-mer on Epithelial Intestinal CACO-2 Cell Inflammatory Response.

Authors:  Antonella Capozzi; Olimpia Vincentini; Pietro Gizzi; Alessandra Porzia; Agostina Longo; Cristina Felli; Vincenzo Mattei; Fabrizio Mainiero; Marco Silano; Maurizio Sorice; Roberta Misasi
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 10.  Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments.

Authors:  Francesco Valitutti; Alessio Fasano
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.